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Abstract The effect of DNA on the surface expression of major
histocompatibility (MHC) class I antigens was examined in non-
hematopoietic tumor cell lines. Transfection with plasmid DNA
via liposome or electroporation significantly increased the
surface expression of MHC class I molecules in a transient
manner. Northern blot analysis showed that levels of MHC class
I mRNA were increased by DNA transfection, probably via
transcriptional activation. In contrast, the expression of the
MHC class II and L-actin genes was not affected, suggesting that
the up-regulation of MHC class I expression by plasmid DNA
works in a gene-specific manner.
z 1998 Federation of European Biochemical Societies.
Key words: Plasmid; Major histocompatibility; Transfection;
Up-regulation; mRNA
1. Introduction
Major histocompatibility (MHC) class I molecules ex-
pressed at the cell surface of virtually all somatic nucleated
cells are composed of a polymorphic heavy chain non-cova-
lently associated with L2-microglobulin, and an antigenic pep-
tide derived from proteins degraded in the cytosol and trans-
ported into the endoplasmic reticulum (for review, see [1]).
Surface levels of MHC class I molecules on antigen presenting
cells are critical to induce an appropriate immune response.
There is plenty of evidence that up- or down-regulation of
MHC class I expression could lead to immunomodulations.
Many types of human cancer are known to be de¢cient of or
low in MHC class I expression compared to their normal
counterparts [2] and many tumorigenic cells lacking MHC
class I molecules are rejected in vivo following MHC class I
gene transfection [3]. In contrast, aberrant increases of MHC
class I levels could contribute to the occurrence of many
pathological conditions including hypomyelination [4] and an-
kylosing enthesopathy [5].
The expression of MHC class I molecules is regulated
mainly at the transcriptional level [6], and cis-acting regula-
tory sequences that are binding sites for transcription factors
including NF-UB, retinoid X receptor and CIITA were shown
to be operational in the expression of the MHC class I genes
[7]. MHC class I expression can be up-regulated by cytokines
including IFN-K, IFN-Q and TNF-K [8,9], and by viral infec-
tion [10]. In addition, it was recently reported that the surface
expression of MHC class I antigens on dendritic cells, which
can capture antigens in peripheral tissues and migrate to sec-
ondary lymphoid organs where they acquire the ability to
stimulate naive T cells, was increased by infection with bac-
teria like Mycobacterium tuberculosis and Streptococcus gor-
donii [11,12] partly via increased stability of MHC class I
protein [11]. However, the factors responsible for the e¡ect
remain to be determined.
Immunological characteristics of DNA, generally viewed as
immunologically inert, have been extensively studied over the
past few years [13]. Bacterial DNA, but not vertebrate DNA,
induced IFN (K,L,Q) secretion, activated NK cell activity, and
inhibited tumor growth [14]. Bacterial DNA also induced B
cells to secrete IL-6 and IgM [15], and spleen cells to secrete
IL-12 and TNF-K [16]. It was previously reported that the
immunomodulatory functions of bacterial DNA were ascribed
to either unmethylated CpG motifs £anked by two 5P purines
and two 3P pyrimidines [17] or a palindromic sequence
AACGTT £anked by strings of 5P and 3P dG residues in 30-
mer oligonucleotides [18]. However, the molecular mecha-
nisms of the immunomodulatory e¡ects of bacterial DNA
remain largely unknown.
In this study, we have examined if bacteria-derived DNA
can modulate the expression of MHC class I antigens. Here
we show that levels of MHC class I antigens on the cell sur-
face of non-hematopoietic tumor cells are up-regulated by
liposome- or electroporation-mediated transfection with plas-
mid DNA, but not by simple addition of the DNA to cul-
tures, in part through the increase of steady state level of
MHC class I mRNA. The stability of MHC class I mRNA
molecules is not changed by plasmid DNA transfection, sug-
gesting that the increased steady state level of MHC class I
mRNA results from transcriptional activation. In contrast,
the expression of the MHC class II and L-actin genes is not
a¡ected.
2. Materials and methods
2.1. Cell lines, cell culture conditions, and monoclonal antibody
The MCA-102 and MCA-207 cell lines, methylcholanthrene-in-
duced ¢brosarcomas, and the CT-26 cell line, a murine colon carci-
noma cell line, have been described previously [9,19], and were main-
tained in DMEM (Gibco-BRL, Gaithersburg, MD, USA) with 10%
FBS, supplemented with antibiotics and glutamine. Hybridoma cell
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lines secreting mAbs 28-8-6s, 34-1-2s and M5/114.15.2 were purchased
from ATCC (Rockville, MD, USA).
2.2. Liposome-mediated transfection
Liposome (lipofectin, Gibco-BRL, Gaithersburg, MD, USA) medi-
ated transfection was carried out as recommended by the supplier.
Cells were seeded at a density of 2U104 cells/well in a 24-well plate
and incubated for 24 h in a CO2 incubator. Cells were washed twice
with serum- and antibiotic-free DMEM and incubated for 24 h in the
presence of DNA-liposome complex in 0.5 ml of serum- and antibi-
otic-free DMEM. Cells were washed twice in PBS, fed with DMEM
supplemented with 10% FBS and antibiotics, and incubated for an
additional 24 h. Cells were harvested for £ow cytometry analysis of
MHC class I expression. For DNA transfection without liposome, all
the procedures were the same except that liposome was deleted. LPS
purchased from Sigma (St. Louis, MO, USA) was dissolved in PBS.
2.3. Electroporation
Electroporation was performed as previously described [20]. Adher-
ent cells were ¢rst resuspended at a concentration of 1U106 cells/0.8
ml in DMEM containing 10% FBS at room temperature. DNA was
added to the cell suspension, incubated at room temperature for
10 min, electroporated (Bio-Rad, Hercules, CA, USA; 960 micro-
farads, 350 mV), and incubated at room temperature for 10 min.
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Fig. 1. Increase of MHC class I expression by transfection with plasmid DNA. After transfection, cells were cultured for 48 h, and harvested
for £ow cytometry analysis of MHC class I expression (H-2KbDb). For a better comparison, the control histogram is shown superimposed. A:
MCA-102 cells were transfected either by liposome with 1 Wg of di¡erent plasmid DNAs (b^d) or by electroporation in the presence of 10 Wg
of pcDNA3.1 DNA (e,f). a: No DNA and no liposome; b: liposome only; c: 1 Wg pcDNA3.1 plus liposome; d: 1 Wg pBR322 plus liposome;
e: mock transfection; f: 10 Wg of pcDNA3.1 DNA. B: MCA-102 cells were transfected with pcDNA3.1 pre-treated with DNAse I via lipo-
some. a: Liposome alone; b: 1 Wg pcDNA3.1 plus liposome; c: 1 Wg pcDNA3.1 pre-treated with DNAse I plus liposome. C: MCA-102 cells
were transfected with di¡erent concentrations of pcDNA3.1 in the presence of liposome. a: 100 pg pcDNA3.1; b: 10 ng pcDNA3.1; c: 1 Wg
pcDNA3.1.
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The electroporated cells were transferred to 5 ml of DMEM contain-
ing 10% FBS, incubated for 48 h in a CO2 incubator, and harvested
for £ow cytometry analysis of MHC I expression.
2.4. Flow cytometry analysis of MHC class I expression
Flow cytometry analysis was carried out by indirect £uorescence
using a FACSorter (Becton Dickinson, Mountain View, CA, USA).
Harvested cells (1.6U105) were washed in PBS containing 2% FBS
and 0.03% NaN3, incubated with primary antibodies (28-8-6s for H-2
KbDb ; 34-1-2s for H-2 KdDd ; M5/114.15.2 for H-2 I-Ab;d;q and I-
Ed;k) appropriately diluted with PBS containing 0.5% BSA for 5 min
at 4‡C, and washed twice in PBS containing 2% FBS and 0.03%
NaN3. Cell pellets were resuspended in PBS containing 0.5% BSA
and further incubated in the presence of FITC-conjugated goat anti-
mouse or anti-rat IgG antibody (Sigma) for 5 min at 4‡C. After being
washed in PBS containing 2% FBS and 0.03% NaN3 twice, cells were
resuspended in PBS containing 0.5% paraformaldehyde, 0.25% BSA
and 0.03% NaN3, and subjected to FACS analysis.
2.5. DNA preparation
A large scale preparation of plasmid DNA (pBR322; pMAL-c2,
New England Biolabs, Beverly, MA, USA; pcDNA3.1, Invitrogen,
San Diego, CA, USA) from Escherichia coli cells (DH5-K, Gibco-
BRL) was carried out basically according to the alkaline lysis method
[21], and further puri¢ed by Qiagen-tip (Qiagen, Hilden, Germany) to
remove RNA, proteins, carbohydrates, and metabolites. Toxic and
mutagenic substances such as phenol, chloroform, and ethidium bro-
mide were not used. The LPS content of the plasmid DNA was de-
termined by the Limulus amebocyte lysate assay (Bio-Whittaker, Wal-
kersville, MD, USA) and the LPS content of all the DNA
preparations was less than 5 ng/Wg DNA.
2.6. DNase I treatment of DNA
For DNase I treatment of DNA, 1 mg of DNA was incubated in
1 ml of 0.1 M Tris-HCl pH 8.0/5 mM MgCl2 containing 1000 U of
DNase I (Promega, Madison, WI, USA) at 37‡C for 5 h, boiled for
10 min to inactivate DNase I and then rapidly cooled on ice, as
previously described [14]. The degradation of DNA was con¢rmed
on 1% agarose gel electrophoresis.
2.7. RNA preparation and Northern blot analysis
RNA preparation and Northern blot analysis were performed as
previously described [20]. The murine K-actin probe was from ATCC
(Rockville, MA, USA) and the MHC class I Kd probe was prepared
by RT-PCR using a pair of primers based on the sequence [22]. The
PCR products were con¢rmed to correspond to their original se-
quence by DNA sequencing.
3. Results
To determine if prokaryotic DNA can modulate the surface
expression of MHC class I antigens, MCA-102 cells, a low
expressor of MHC class I H-2KbDb molecules, were incu-
bated with various concentrations of pcDNA3.1, an eucary-
otic expression vector. We used plasmid DNA instead of bac-
terial DNA as immunomodulators, because (i) both plasmid
and bacterial DNAs share for immunostimulatory functions
essential features such as unmethylated CpG dinucleotides
present in multiple copies [23], (ii) plasmid DNA is structually
less complex than bacterial DNA, and (iii) it is easy to handle
and prepare. A simple addition of various amounts of
pcDNA3.1 from 0 to 50 Wg and a subsequent incubation for
48 h were not e¡ective in the modulation of the surface ex-
pression of MHC class I molecules (data not shown). Intra-
cellular transport of extracellular DNA into mammalian cells
could be facilitated by liposome [24] or electroporation [25].
Therefore, we examined if e⁄cient intracellular transport of
pcDNA3.1 may have modulatory e¡ects on MHC class I ex-
pression. MCA-102 cells were analyzed for MHC class I ex-
pression 48 h after transfection with pcDNA3.1 complexed
with liposome. Untreated MCA-102 cells showed minimal
staining with anti-H-2KbDb antibodies with a mean £uores-
cence of 50 (Fig. 1A,a). Liposome treatment alone had little, if
any, modulatory e¡ect on MHC class I expression (Fig.
1A,b). However, 1 Wg of pcDNA3.1 complexed with liposome
signi¢cantly enhanced the surface level of MHC class I pro-
teins to mean £uorescence value of 200 (Fig. 1A,c). Other
types of plasmid DNAs including pBR322, a subcloning vec-
tor (Fig. 1A,d), and pMAL-c2, a procaryotic expression vec-
tor (data not shown), prepared from E. coli cells were also
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Fig. 2. E¡ects of pcDNA3.1 on MHC class I expression in CT-26 cells expressing H-2KdDd antigens. After transfection, cells were cultured for
48 h, and harvested for £ow cytometric analysis of MHC class I expression (H-2KdDd). a, e: No DNA and no liposome; b, f: liposome alone;
c, g: 1 Wg pcDNA3.1 plus liposome; d, h: 1 Wg pcDNA3.1 pre-treated with DNase I plus liposome. Surface expression of MHC class I anti-
gens in CT-26 cells (a^d) was analyzed under the same instrument conditions set for MCA-102 cells. To improve resolution among samples (a^
d) the intensity scale was shifted to the left and analyzed (e^h). The control histogram (e) is shown superimposed.
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capable of up-regulating the surface expression of MHC class
I molecules as e¡ectively as pcDNA3.1. When transfection
was performed by electroporation, surface levels of MHC
class I molecules were also increased 3^4-fold by the addition
of plasmid DNA (Fig. 1A,e,f). And pre-treatment of
pCDNA3.1 with DNase I reverted the e¡ect of the DNA
(Fig. 1B).
The plasmid DNAs used in these studies were contaminated
with small amounts of LPS (less than 5 ng/Wg DNA) whose
function on the regulation of MHC class I expression is con-
troversial [26,27]. In our system, no detectable e¡ect of LPS
(up to 10 Wg) on the expression of MHC class I antigens was
observed (data not shown).
We next determined the e¡ective range of DNA dosage in
modulating MHC class I expression. Levels of MHC class I
antigens increased as the concentration of DNA increased
(Fig. 1C), reaching the maximum level at 1 Wg. No further
increase was observed with more than 1 Wg up to 100 Wg (data
not shown). Less than 10 ng DNA was not e¡ective (Fig.
1C,a).
Kinetic analyses of the expression of MHC class I antigens
by liposome-mediated plasmid DNA transfection showed that
surface levels of MHC class I expression in MCA-102 cells
were transiently increased, reaching a maximum level 2 days
after transfection (data not shown).
The up-regulatory e¡ects of plasmid DNA on MHC class I
expression shown in MCA-102 cells were also observed with
two other tumor cell lines, MCA-207 cells which express com-
parable levels of MHC class I H-2KbDb molecules (data not
shown), and CT-26 cells which express high levels of H-
2KdDd antigens (Fig. 2). Given all the above results, it is
likely that plasmid DNA up-regulates the surface expression
of MHC class I antigens when e⁄ciently transfected into dif-
ferent kinds of cells.
To get some insight into molecular mechanisms underlying
the increased surface expression of MHC class I antigens by
plasmid DNA, Northern blot analysis was performed. North-
ern blot analysis with 20 Wg of total RNA revealed that levels
of MHC class I mRNA were increased about 3-fold by plas-
mid DNA transfection (Fig. 3). The enhancing e¡ect of DNA
was abolished by pre-treatment with DNase I (Fig. 3, lane 4).
No change in levels of L-actin mRNA molecules, which were
used as an internal control, was observed.
We next examined if plasmid DNA transfection could in-
crease the stability of MHC class I mRNA. Since actinomycin
D blocks RNA synthesis, the decrease in mRNA concentra-
tions caused by its presence should be a measure of RNA
stability. Fig. 4 shows that levels of MHC class I mRNA
from non-transfected cells are slightly reduced within 10 h
of treatment, and so are those from plasmid-DNA transfected
cells, although the relative concentrations are di¡erent, sug-
gesting that plasmid DNA does not change the stability of
MHC class I mRNA. The half-life of K-actin mRNA under
the same conditions was approximately 1.5 h.
We next examined whether expression of genes other than
the MHC class I genes is modulated by DNA. Neither surface
expression of class II MHC antigens (data not shown) nor the
level of L-actin RNA (Fig. 3) in MCA-102 cells was changed
by DNA transfection.
4. Discussion
In the present study, we have demonstrated that the surface
expression of MHC class I antigens in tumor cell lines of non-
hematopoietic origin is up-regulated by plasmid DNA, only
when transfection was facilitated by liposome or electropora-
tion. However, neither the surface expression of class II MHC
antigens nor levels of actin RNA are modulated, suggesting
that the e¡ects of DNA on gene expression are gene-speci¢c.
Plasmid DNA seems to exert its e¡ects on MHC class I ex-
pression at the level of transcription.
In contrast to previous reports in which the mere presence
of bacterial DNA in culture medium was able to enhance
immune responses [14^16], in our study no discernable e¡ect
on MHC class I expression was induced by spontaneous
transfection of plasmid DNA. The cell types previously used
are of hematopoietic origin including macrophages and den-
dritic cells, which are able to take up extracellular antigens. In
fact, internalization of bacterial DNA rather than DNA bind-
ing to a cell surface receptor was necessary for proper activa-
tion of macrophages [28]. However, the non-hematopoietic
tumor cell lines used in the present study, which lack inherent
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Fig. 3. Increase of MHC class I mRNA by plasmid DNA transfec-
tion. MCA-102 cells were transfected under di¡erent conditions, cul-
tured for 48 h, and harvested for RNA. Twenty Wg of cytoplasmic
RNA were size-fractionated by formaldehyde/agarose gel electropho-
resis, and hybridized to probes for murine MHC class I H-2Kb or
K-actin. Lane 1: Medium; lane 2: liposome; lane 3: 1 Wg
pcDNA3.1 plus liposome; lane 4: 1 Wg pcDNA3.1 pre-treated with
DNase I plus liposome.
Fig. 4. Actinomycin D treatment of MCA-102 cells. 2U105 MCA-
102 cells were transfected in the absence or presence of 10 Wg
pcDNA3.1. Forty-eight h after transfection, actinomycin D (5 Wg/
ml; Sigma) was added to the medium of the cell cultures for the in-
dicated periods and harvested for RNA. Twenty Wg of cytoplasmic
RNA were size-fractionated by formaldehyde/agarose gel electropho-
resis, and hybridized to probes for murine MHC class I H-2Kb or
K-actin.
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phagocytic ability, might be able to modulate expression of
certain genes like MHC class I if provided with plasmid DNA
intracellulary via liposome or electroporation.
In this study, we have demonstrated that the increased cell
surface expression of MHC class I antigens by plasmid DNA
transfection is closely associated with an increase of MHC
class I mRNA. It was previously reported that in dendritic
cells bacteria induced synthesis of MHC class I molecules and
increased the stability of MHC class I proteins [11]. However,
they did not examine transcriptional regulation of MHC class
I molecules. In this study, we have shown that the half-life of
MHC class I mRNA is not changed by plasmid DNA trans-
fection. MHC class I expression is regulated mainly at the
transcriptional level [6], although there are some exceptions
[29,30]. Stacey et al. [28] showed that bacterial DNA induced
TNF-K mRNA and increased transcription factor NF-UB
DNA binding activity in macrophages. In our study, trans-
fection of MCA-102 cells with plasmid DNA showed no ef-
fects on the mRNA level of TNF-K, IFN-K and IFN-Q genes
and on the biological activity of TNF-K (data not shown).
When we measured NF-UB activity under the conditions pre-
viously reported [20,31], MCA-102 cells constitutively ex-
pressed NF-UB activity which was not further modulated by
DNA transfection (data not shown). At present, we do not
know the molecular mechanisms of the increased expression
of MHC class I mRNA by plasmid DNA transfection in non-
hematopoietic tumor cells used in the present study. We spec-
ulate that plasmid DNA enhances the expression of MHC
class I mRNA via activating some transcription factors other
than NF-UB, which are currently under investigation.
In our study, the expression of MHC class II antigens and
L-actin in MCA-102 cells was not modulated by DNA trans-
fection, suggesting that the e¡ect of plasmid DNA on gene
expression is gene-speci¢c. At present, we do not know how
many other genes are responding to transfected plasmid
DNA. If the e¡ect of plasmid DNA is gene-speci¢c, the ques-
tion is ‘Does the up-regulation of MHC class I molecules by
plasmid DNA transfection in non-hematopoietic cells contrib-
ute to immunity to invading pathogens?’. Many tumor cell
lines have been shown to present tumor associated antigens
directly to CD4 and CD8 T cells [32,33]. Immunity against
most bacteria is exerted by phagocytic cells including macro-
phages and neutrophils. However, many bacterial species such
as Legionella dumo⁄i and Helicobacter pylori can grow in
epithelial cells [34,35], which may act as antigen presenting
cells after bacterial infection.
In the £ow cytometric analysis of MHC class I antigens in
the present study, almost 100% of MCA-102 and CT-26 cells
treated with plasmid DNA by liposome or electroporation
showed increased expression of MHC class I antigens. It
was previously reported that liposome and electroporation
e⁄ciently transfected many kinds of mammalian cells at a
very high frequency up to 95^100% [36,37], which may ac-
count for the ¢ndings in this study. Alternatively, some other
factors, other than TNF-K, IFN-K and IFN-Q which are
known to increase expression of MHC class I antigens, may
be responsible for the augmentation of MHC class I expres-
sion by plasmid DNA transfection. We are currently examin-
ing the possibility.
Many types of human cancer are de¢cient of MHC class I
molecules and can be curable by MHC class I gene transfec-
tion [2,3]. Although we do not know the molecular mecha-
nisms of the enhancing e¡ects of plasmid DNA on the surface
expression of MHC class I genes, it may be of practical inter-
est to use exogenous DNA in cancer therapy.
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